Education
About Us
Working with TipRanks
Follow Us
Beam Therapeutics (BEAM)
NASDAQ:BEAM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 63.52M | $ 377.71M | $ 60.92M | $ 51.84M | $ 24.00K |
| Gross Profit | $ 63.52M | $ -59.67M | $ 38.34M | $ 35.40M | $ -103.16M |
| Operating Income | $ -415.57M | $ -176.49M | $ -338.48M | $ -392.46M | $ -132.76M |
| EBITDA | $ -415.57M | $ -156.47M | $ -324.33M | $ -392.46M | $ -128.03M |
| Net Income | $ -376.74M | $ -132.53M | $ -263.59M | $ -341.36M | $ -256.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 850.74M | $ 1.19B | $ 1.08B | $ 965.65M | $ 299.67M |
| Total Assets | $ 1.10B | $ 1.46B | $ 1.34B | $ 1.47B | $ 451.68M |
| Total Debt | $ 161.43M | $ 172.69M | $ 179.00M | $ 142.35M | $ 100.23M |
| Net Debt | $ -120.54M | $ -263.21M | $ -53.76M | $ -823.30M | $ -61.94M |
| Total Liabilities | $ 370.28M | $ 478.38M | $ 608.24M | $ 647.72M | $ 206.12M |
| Stockholders' Equity | $ 733.54M | $ 981.33M | $ 733.47M | $ 826.74M | $ 245.56M |
| Cash Flow | |||||
| Free Cash Flow | $ -356.19M | $ -182.93M | $ -26.42M | $ -113.08M | $ -112.10M |
| Operating Cash Flow | $ -347.25M | $ -149.19M | $ 22.53M | $ -66.27M | $ -95.74M |
| Investing Cash Flow | $ 185.01M | $ 71.84M | $ -461.34M | $ -294.14M | $ -100.12M |
| Financing Cash Flow | $ 7.74M | $ 276.45M | $ 111.59M | $ 756.14M | $ 322.32M |